NCT05251467Completed
A Comprehensive Approach To Relief Of Digestive Symptoms In Cystic Fibrosis: CARDS-CF
Source: ClinicalTrials.gov · Last updated 22 Jul 2024
Brief summary (registry, in English)
Development of a new patient reported outcome measure (PROM) that will measure the daily burden of gastrointestinal symptoms over the previous 24 hour period for people with cystic fibrosis.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 350 (actual)
- First submitted
- 4 Feb 2022
- Start date
- 28 Feb 2022
- Primary completion date
- 3 Dec 2023
- Lead sponsor
- Nottingham University Hospitals NHS Trust
- Diseases
- Cystic fibrosis
- NCT number
- NCT05251467
What you commit to
- Study type: Observational
- Participants enrolled: 350
- From 28 Feb 2022 to the primary completion date, 3 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- \< 12 years age
Other
- Unable to give informed consent
Who the study is looking for
- People with cystic fibrosis age 12 years and over
- Confirmed diagnosis of cystic fibrosis based on genotype or sweat chloride testing
- Capacity to consent, or to understand the requirements of the study where parental consent is required
Age in the registry: 12 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nottingham University Hospitals NHS Trust Coordinator of this site? Confirm its status | Nottingham | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.